Article Details
Retrieved on: 2018-04-14 16:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> LLC MA continued to hold its position in Orexigen Therapeutics, Inc. (NASDAQ:OREX) during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,226,839 shares of the biopharmaceutical company's stock at the end of the fourth quarter. <b>Baupost Group</b> LLC MA ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here